Supply Chain to Value Chain Together Adding Value
Total Page:16
File Type:pdf, Size:1020Kb
21 - 22 MARCH 2018 THE OAKLEY COURT, WINDSOR, UK SUPPLY CHAIN TO VALUE CHAIN TOGETHER ADDING VALUE CO-ORGANISED BY GIRP AND HDA UK SUPPLY CHAIN TO VALUE CHAIN WINDSOR, UK TOGETHER ADDING VALUE 21 – 22 MARCH 2018 CONFERENCE PROGRAMME CONFERENCE OBJECTIVES • Present the latest state-of-the-art technologies in temperature-controlled transportation • Demonstrate how collaboration can move the supply chain towards a true pharmaceutical value chain • Further the dialogue between supply chain actors and GMDP inspectors • Engage participants in further reflections on how to harness the additional benefits from the serialisation project in Europe • Explore new options for value creation within the healthcare ecosystem • Explore the impact of Brexit on the British and European pharmaceutical value chains TOPICS TO BE ADRESSED • Handling temperature sensitive products • Temperature controlled storage, monitoring and transportation • Experiences from GMDP inspections • Medicines batch tracking requirements • Electronic delivery notes • Responsibilities of responsible person • Implementation of the Falsified Medicines Directive 5 KEY TAKE-AWAYS • Deep and concrete insight on how to secure an end-to-end temperature-controlled supply chain • Clear understanding of GMDP inspectors’ expectations • How to further advance with GDP implementation at national level • How to improve business processes with serialisation • How to collaborate with your value chain partners Rue de la Loi 26, Box 14 T +32 (0)2 777 99 77 E [email protected] 1040 Brussels, Belgium F +32 (0)2 770 36 01 W www.girp.eu SUPPLY CHAIN TO VALUE CHAIN WINDSOR, UK TOGETHER ADDING VALUE 21 – 22 MARCH 2018 CONFERENCE DAY 1 – WEDNESDAY 21 MARCH 2018 12:30 Welcome Lunch 14:00 Opening & Welcome Address • Mr René Jenny, President, European Healthcare Distribution Association (GIRP) • Mr Martin Sawer, Executive Director, Healthcare Distribution Association, United Kingdom (HDA UK) 14:15 Session 1: Seamless handling of temperature sensitive products from production to patient Keynote address • Dr. Rafik Bishara, Technical Advisor – A review of best practices Panel discussion Moderator: Dr. Rafik Bishara, Technical Advisor • Mr Fabian de Paoli, Vaccine Distribution & Cold Chain, GSK Biologicals • Mr Claude Jolicoeur, Director Regulatory Affairs, Corporate GMP officer, McKesson Canada • Mr Thomas de Bie, CEO, CAPPI • Mr Markus Haase, Pharma International Senior Market Manager, Testo Panel discussion with speakers 15:30 Coffee Break 16:00 Session 2: Collaborative approaches to temperature-controlled storage, monitoring and transportation Moderator: Mr Olivier Simonnot, Strategic Marketing Manager Life Sciences EMEA, Sensitech • Mr Bertrand Nicolau, Distribution and Quality Assurance Director, Supply Chain, Servier and Mr Petr Dvorak, Group Sales Director, PHOENIX • Dr. Erik van Asselt, Cold Chain Improvement Manager, Vaccines, MSD Netherlands • Mr Roland Duquesne, Director, Strategic Accounts, OEM and Vertical Markets, ThermoKing Panel discussion with speakers 17:30 Keynote address • Mr Mike Thompson, CEO, Association of the British Pharmaceutical Industry (ABPI) 18:00 Concluding remarks • Ms Monika Derecque Pois, Director General, European Healthcare Distribution Association (GIRP) 18:15 End of Conference Day 1 19:30 Networking Reception & Dinner Rue de la Loi 26, Box 14 T +32 (0)2 777 99 77 E [email protected] 1040 Brussels, Belgium F +32 (0)2 770 36 01 W www.girp.eu SUPPLY CHAIN TO VALUE CHAIN WINDSOR, UK TOGETHER ADDING VALUE 21 – 22 MARCH 2018 CONFERENCE DAY 2 – THURSDAY 22 MARCH 2018 9:00 Opening remarks • Ms Monika Derecque Pois, Director General, European Healthcare Distribution Association (GIRP) 9:15 Session 3: Conversation with G(M)DP Inspectors: Ask the questions you never dared Introduction • Mr Andrei Spinei, Scientific Administrator, European Medicines Agency Inspectors’ panel Topics: transport temperature and temperature excursion handling, digital delivery documentation, overview of wholesale distribution licenses, responsibilities of the responsible person, batch tracking requirements, temperature mapping Moderator: Dr. Rafik Bishara, Technical Advisor • Mr Andreas Krassnigg, Head of GMDP Inspections Department, Austrian Agency for Health and Food Safety • Ms Emer O’Neill, Health Products Distribution Inspections Co-ordinator, Irish Health Products Regulatory Authority • Ms Ethel Mertens, Director General Inspection, Belgian Federal Agency for Medicines and Health Products • Ms Jacqueline Masayi, GDP Inspector (Inspection, Enforcement & Standards Division), Medicines & Healthcare products Regulatory Agency (United Kingdom) • Dr. Ibolya Tarjáni, Head of Department of Inspectorate (Directorate of Inspection and Technology), OGYÉI, Hungarian National Institute of Pharmacy and Nutrition Registered participants will have the possibility to send questions in advance 10:30 Coffee break 11:00 Inspectors’ panel continued 13:00 Lunch Rue de la Loi 26, Box 14 T +32 (0)2 777 99 77 E [email protected] 1040 Brussels, Belgium F +32 (0)2 770 36 01 W www.girp.eu SUPPLY CHAIN TO VALUE CHAIN WINDSOR, UK TOGETHER ADDING VALUE 21 – 22 MARCH 2018 14:00 Session 4: Medicines Verification in Europe – how does it work in practice? Moderator: Mr Graham Smith, General Manager, EMEA Special Projects, Tracelink • Mr Andreas Walter, General Manager, European Medicines Verification Organisation (EMVO) • Mr Charles Young, Business Unit Lead, Solidsoft Reply • Mr Pascal Aulagnet, Global Serialization Program Client Partner, Pfizer • Mr Grant Courtney, Manager Falsified Medicines Directive Project, GSK Panel discussion with speakers 15:30 Coffee Break 16:00 Session 5: The End Game – connecting all end-users to the national systems Moderator: Mr Hitesh Varambhia, Life Sciences Business Development Director, Adents • Mr Jerome Bertin, General Manager, SecurMed UK • Mr Stefan Moch, Head of the NMVO-Business, Arvato • Mr Christian Taylor, Business Consultant, Zetes UK • Mr Marco Steinkamp, Global Sales Director Track & Trace, Movilitas • Mr John Preston, Head of Offsite Dispensing Solutions and Falsified Medicines, Phoenix Healthcare Distribution Ltd. Panel discussion with speakers 17:30 Closing remarks and farewell • Ms Monika Derecque-Pois, Director General, European Healthcare Distribution Association (GIRP) • Mr Martin Sawer, Executive Director, Healthcare Distribution Association, United Kingdom (HDA UK) WE THANK OUR CONFERENCE PARTNERS FOR THEIR VALUABLE SUPPORT Rue de la Loi 26, Box 14 T +32 (0)2 777 99 77 E [email protected] 1040 Brussels, Belgium F +32 (0)2 770 36 01 W www.girp.eu .